Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 1
2009 pubmed

Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus.

Senyürek. Ilknur I; Paulmann. Maren M; Sinnberg. Tobias T; Kalbacher. Hubert H; Deeg. Martin M; Gutsmann. Thomas T; Hermes. Marina M; Kohler. Thomas T; Götz. Fritz F; Wolz. Christiane C; Peschel. Andreas A; Schittek. Birgit B

Key Findings

  • DCD‑derived peptides kill Staphylococcus aureus without forming membrane pores
  • Bacterial killing is followed by membrane depolarization and inhibition of RNA/protein synthesis
  • DCD peptides bind weakly to bacterial envelope components, unlike LL‑37 which binds strongly

Practical Outcomes

  • For now the findings are mostly scientific and don’t give a clear recipe for using DCD peptides in health hacks. They hint that DCD‑based skin or topical products might offer a different antimicrobial approach, but more work is needed before any dosage or protocol can be recommended.

Summary

The study shows that natural skin peptides called DCD work differently from the well‑known peptide LL‑37 to kill Staph bacteria. DCD peptides kill bacteria over time, cause the bacterial membrane to lose its charge, and block the bacteria’s ability to make RNA and proteins, but they don’t punch holes in the membrane like LL‑37 does. They also stick only weakly to bacterial surface components.

Abstract

Dermcidin (DCD) is an antimicrobial peptide which is constitutively expressed in eccrine sweat glands. By postsecretory proteolytic processing in sweat, the DCD protein gives rise to anionic and cationic DCD peptides with a broad spectrum of antimicrobial activity. Many antimicrobial peptides induce membrane permeabilization as part of their killing mechanism, which is accompanied by a loss of the bacterial membrane potential. In this study we show that there is a time-dependent bactericidal activity of anionic and cationic DCD-derived peptides which is followed by bacterial membrane depolarization. However, DCD-derived peptides do not induce pore formation in the membranes of gram-negative and gram-positive bacteria. This is in contrast to the mode of action of the cathelicidin LL-37. Interestingly, LL-37 as well as DCD-derived peptides inhibit bacterial macromolecular synthesis, especially RNA and protein synthesis, without binding to microbial DNA or RNA. Binding studies with components of the cell envelope of gram-positive and gram-negative bacteria and with model membranes indicated that DCD-derived peptides bind to the bacterial envelope but show only a weak binding to lipopolysaccharide (LPS) from gram-negative bacteria or to peptidoglycan, lipoteichoic acid, and wall teichoic acid, isolated from Staphylococcus aureus. In contrast, LL-37 binds strongly in a dose-dependent fashion to these components. Altogether, these data indicate that the mode of action of DCD-derived peptides is different from that of the cathelicidin LL-37 and that components of the bacterial cell envelope play a role in the antimicrobial activity of DCD.

Study Information

Provider

pubmed

Year

2009

Date

2009-04-13T00:00:00.000Z

DOI

10.1128/aac.01679-08